3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:千円) |
| 前連結会計年度 (2025年1月31日) | 当連結会計年度 (2026年1月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 2,921,402 | 15,083,233 |
前渡金 | 269,881 | 198,936 |
その他 | 144,296 | 207,376 |
流動資産合計 | 3,335,580 | 15,489,546 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物 | 22,943 | 27,200 |
工具、器具及び備品 | 33,522 | 71,034 |
減価償却累計額 | △24,906 | △29,119 |
建設仮勘定 | 8,761 | - |
有形固定資産合計 | 40,319 | 69,115 |
無形固定資産 | 43,891 | 43,891 |
投資その他の資産 | | |
その他 | 27,547 | 18,986 |
投資その他の資産合計 | 27,547 | 18,986 |
固定資産合計 | 111,759 | 131,993 |
資産合計 | 3,447,339 | 15,621,539 |
負債の部 | | |
流動負債 | | |
1年内返済予定の長期借入金 | 268,000 | 129,000 |
未払金 | 139,077 | 165,452 |
未払費用 | 304,830 | 212,671 |
未払法人税等 | 345 | 1,210 |
賞与引当金 | 9,593 | 12,523 |
その他 | 10,230 | 13,436 |
流動負債合計 | 732,076 | 534,293 |
固定負債 | | |
転換社債型新株予約権付社債 | - | 1,109,700 |
長期借入金 | 129,000 | - |
繰延税金負債 | 823,340 | 372,879 |
固定負債合計 | 952,340 | 1,482,579 |
負債合計 | 1,684,417 | 2,016,873 |
純資産の部 | | |
株主資本 | | |
資本金 | 2,496,192 | 8,375,431 |
資本剰余金 | 6,207,634 | 12,086,873 |
利益剰余金 | △698,901 | △995,899 |
自己株式 | △1,128 | △1,164 |
株主資本合計 | 8,003,796 | 19,465,240 |
その他の包括利益累計額 | | |
為替換算調整勘定 | △6,448,629 | △6,126,751 |
その他の包括利益累計額合計 | △6,448,629 | △6,126,751 |
新株予約権 | 207,754 | 266,177 |
純資産合計 | 1,762,921 | 13,604,666 |
負債純資産合計 | 3,447,339 | 15,621,539 |
E3138245920サンバイオ株式会社SanBio Company Limited通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-02-012026-01-31FY2026-01-312024-02-012025-01-312025-01-311falsefalsefalse459202025-02-012026-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202025-02-012026-01-31jppfs_cor:ShareholdersEquityMember459202025-02-012026-01-31jppfs_cor:RetainedEarningsMember459202025-02-012026-01-31jppfs_cor:CapitalSurplusMember459202025-02-012026-01-31jppfs_cor:CapitalStockMember459202025-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMember459202025-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202025-01-31jppfs_cor:ShareholdersEquityMember459202025-01-31jppfs_cor:RetainedEarningsMember459202025-01-31jppfs_cor:CapitalSurplusMember459202025-01-31jppfs_cor:CapitalStockMember459202024-02-012025-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMember459202024-02-012025-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202024-02-012025-01-31jppfs_cor:ShareholdersEquityMember459202024-02-012025-01-31jppfs_cor:RetainedEarningsMember459202024-02-012025-01-31jppfs_cor:CapitalSurplusMember459202024-02-012025-01-31jppfs_cor:CapitalStockMember459202024-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMember459202026-03-17459202026-01-31459202025-02-012026-01-31459202025-01-31459202024-02-012025-01-31459202024-01-31459202024-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202024-01-31jppfs_cor:ShareholdersEquityMember459202024-01-31jppfs_cor:RetainedEarningsMember459202024-01-31jppfs_cor:CapitalSurplusMember459202024-01-31jppfs_cor:CapitalStockMember459202026-01-31jppfs_cor:SubscriptionRightsToSharesMember459202025-01-31jppfs_cor:SubscriptionRightsToSharesMember459202024-02-012025-01-31jppfs_cor:TreasuryStockMember459202024-01-31jppfs_cor:TreasuryStockMember459202026-01-31jppfs_cor:TreasuryStockMember459202025-02-012026-01-31jppfs_cor:TreasuryStockMember459202025-01-31jppfs_cor:TreasuryStockMember459202025-02-012026-01-31jppfs_cor:SubscriptionRightsToSharesMember459202024-01-31jppfs_cor:SubscriptionRightsToSharesMember459202024-02-012025-01-31jppfs_cor:SubscriptionRightsToSharesMember459202026-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMember459202026-01-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember459202026-01-31jppfs_cor:ShareholdersEquityMember459202026-01-31jppfs_cor:RetainedEarningsMember459202026-01-31jppfs_cor:CapitalSurplusMember459202026-01-31jppfs_cor:CapitalStockMember459202025-02-012026-01-31jppfs_cor:ValuationAndTranslationAdjustmentsMemberiso4217:JPYxbrli:pure